Form 424B5 REGENXBIO Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Regenxbio Inc. (RGNX) PT Raised to $40 at Stifel
March 7, 2024 10:39 AM ESTStifel analyst Annabel Samimy raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $40.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy on RGNX and raise TP to $40 after another meaningful RGX-202 update from the AFFINITY-DUCHENNE Ph.1/2... More
